Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium

Jennifer Schmidt1, Kristin Friebel, Roland Schönherr

  • 1Institute of Pathology, University of Regensburg, Franz-Josef-Strauss-Allee 11, D-93053 Regensburg, Germany.

Cell Research
|August 25, 2010
PubMed

Insights

Melanoma inhibitory activity (MIA) aids cancer spread by detaching cells. This study reveals MIA secretion at cell rear, facilitated by KCa3.1 channels, promoting melanoma cell migration and metastasis.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Malignant melanoma is an aggressive skin cancer.
  • Melanoma inhibitory activity (MIA) promotes metastasis by interacting with integrins.
  • MIA facilitates cell detachment and the formation of metastases.

Purpose of the Study:

  • To investigate the secretion pathway and cellular localization of MIA.
  • To elucidate the role of intracellular Ca(2+) and KCa3.1 channels in MIA secretion.
  • To understand the mechanism by which MIA promotes melanoma cell migration.

Main Methods:

  • Immunofluorescence microscopy to visualize MIA localization in migrating and non-migrating cells.
  • Analysis of MIA secretion pathway using COPI- and COPII-dependent transport inhibitors.
  • Assessment of KCa3.1 channel activity using specific inhibitors (TRAM-34) and dominant-negative mutants.
  • Measurement of intracellular Ca(2+) levels during MIA secretion.

Main Results:

  • MIA secretion is localized to the rear of migrating melanoma cells.
  • MIA accumulates in the actin cortex of non-migrating cells.
  • MIA utilizes a conventional secretory pathway involving COPI and COPII.
  • Intracellular Ca(2+) ions are crucial for MIA release.
  • The KCa3.1 potassium channel supports MIA secretion at the cell rear.
  • Inhibition of KCa3.1 channels reduced MIA secretion and cell migration.

Conclusions:

  • MIA transport to the cell rear is linked to cell migration.
  • KCa3.1 potassium channels play a novel role in promoting melanoma cell migration by regulating MIA secretion.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...